Japan’s ‘anticancer-CNS’ vs Korea’s ‘anticancer-antidiabetic’
The current environment of the Korean pharmaceutical industry is evaluated as similar to the Japanese 1990s in many aspects, such as the amount of sales, the R&D development steps and the government’s drug pricing policy.
However, the biggest difference is their focus in regards to senile disea...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
